Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ALZHEIMER DISEASE, SUSCEPTIBILITY TO
|
3 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.700 | 0 | |||||||
HEMOCHROMATOSIS, JUVENILE, DIGENIC
|
1 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.700 | 0 | |||||||
MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 7 (finding)
|
2 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.700 | 0 | |||||||
Neoplastic Syndromes, Hereditary
|
6387 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.700 | 0 | |||||||
PORPHYRIA CUTANEA TARDA, SUSCEPTIBILITY TO
|
1 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.700 | 0 | |||||||
PORPHYRIA VARIEGATA, SUSCEPTIBILITY TO
|
1 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.700 | 0 | |||||||
TRANSFERRIN SERUM LEVEL QUANTITATIVE TRAIT LOCUS 2
|
2 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.700 | 0 | |||||||
HEMOCHROMATOSIS, TYPE 1
|
62 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.900 | 0.976 | 248 | 1996 | 2019 | ||||
Hereditary hemochromatosis
|
56 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.800 | 0.973 | 260 | 1997 | 2019 | ||||
Hemochromatosis
|
45 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.100 | 0.974 | 230 | 1997 | 2019 | ||||
Iron Overload
|
53 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.100 | 0.946 | 167 | 1997 | 2019 | ||||
Liver diseases
|
100 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.100 | 0.895 | 19 | 1998 | 2019 | ||||
Porphyria Cutanea Tarda
|
39 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.100 | 0.889 | 18 | 1998 | 2014 | ||||
Hepatitis C
|
347 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.100 | 0.882 | 17 | 1998 | 2020 | ||||
Hypocalciuric hypercalcemia, familial, type 1
|
58 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.100 | 1.000 | 12 | 1998 | 2007 | ||||
Iron deficiency
|
13 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.100 | 1.000 | 11 | 1998 | 2014 | ||||
Hepatitis C, Chronic
|
80 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.070 | 0.857 | 7 | 1998 | 2020 | ||||
Fatty Liver Disease
|
81 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.060 | 1.000 | 6 | 1998 | 2012 | ||||
Anemia, Hemolytic
|
31 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.030 | 1.000 | 3 | 1998 | 2009 | ||||
Meconium ileus
|
16 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.030 | 1.000 | 3 | 1998 | 2019 | ||||
Steatohepatitis
|
75 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.030 | 0.667 | 3 | 1998 | 2009 | ||||
Cardiomyopathies
|
294 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.020 | 0.500 | 2 | 1998 | 2001 | ||||
Cystic Fibrosis
|
704 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.020 | 1.000 | 2 | 1998 | 2003 | ||||
Siderosis
|
2 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.020 | 1.000 | 2 | 1998 | 2010 | ||||
Fibrosis, Liver
|
64 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.100 | 1.000 | 10 | 1999 | 2015 |